2016/05/12 16:03 
主訴(Chief Complaint) 
Informant:family
Loss of consciousness at 2016/05/12 06:00 
病史(Brief History) 
Present illness:
    The 62-year-old man had colon cancer, adenocarcinoma, splenic flexure, pT4aN1bM0, stage IIIB, status post loop T-colostomy (2014/4/15), status post laparoscopic left hemicolectomy and protective loop ileostomy (2014/4/22), status post FOLFOX (I, 2014/5/27), status post closure of loop ileostomy (2014/7/11), PD with liver mets, status post RFA (II), status post FOLFIRI (I, 2015/5/29), PD with peritoneal seeding and pleural mets, status post right hemicolectomy + intra-abdominal seeding excision + intraabdominal chemotherapy + ileostomy (2015/7/29), s/p FOLFOXFIRI + Avastin (IV, C1D1=2015/9/14 ~ C4D1=2015/12/12), status post FOLFIRI (II, C1D1=2016/1/28 ~ C2D1=2016/2/20), status post FOLFIRI + AVASTIN (I, 2016/04/16)
    
    Initially, he presented abdominal pain for 1 month in 2014/03, he had ever search for medical help and colonoscope was performed by local medical department physician, which showed a descending-colon tumor, 40cm AAV, 2.0cm circular, cauliflower and irregular mass, the biopsy was performed and showed tubular adenoma, moderate to severe dysplsia. he went to Dr.梁金銅's OPD for second opinion on 2014/04/10 and he was then admitted to general surgical ward for further evaluation and treatment. Abdominal and pelvis CT on 4/14 showed suspicious tumor at the proximal descending colon. Due to the obstruction of the colon, loop T-colostomy was performed smoothly on 2014/4/15. He received laparoscopic left hemicolectomy with protective ileostomy smoothly on 4/23. Pathology report on 4/28 showed adenocarcinoma, pT4aN1bM0, stage IIIB, port-A was implanted and chemotherapy with FOLFOX (I) was given on 2014/5/27. Stomy closure was done on 2014/07/11.
    However, RIA:CEA (Serum) increased to 15.8 ng/ml(6.83 ng/ml this April), and whole body FDG(PET) showed probable viable malignancies at hepatic surface and peritoneal cavity. Under the impression of colon cancer with liver metastasis, he was admitted for RFA for liver metastasis  on 2015/05/28, then receive FOLFIRI (I) on 2015/05/29. Right hemicolectomy + intra-abdominal seeding excision + hepatic RFA + intra-abdominal chemotherapy + ileostomy were performed on 2015/7/29. He developed dyspnea and was admitted on 2015/09/10, pleural effusion cytology revealed adenocarcinoma, metastatic; FOLFOXFIRI + AVASTIN (I) was administrated on 2015/9/14, and FOLFOXFIRI + AVASTIN (II) on 2015/10/14, C3D1=2015/12/12 on 2015/11/15, C4D1=2015/12/12, 
. 2015/10/15 PET showed new hot areas at right neck and bilateral pleura, Regorafenib was started since 2015/12/14-2016/02. FOLFIRI C1D1=2016/01/28 and C2D1= 2016/02/20. CT With/Without Contrast-Abdomen on 2016/02/20 showed multiple peritoneal seeding tumors, smaller. PET study on 2016/04/13 revealed diffuse FDG-avid lesions at bilateral pleura, left lung, right lobe of liver and peritoneum. He was admitted to our ward for the scheduled chemotherapy with FOLFIRI + AVASTIN on 2016/04/16(C1D1=2016/04/16). 
    He came to our ER on 2016/05/06 for dyspnea, and was treated as lung edema, diuretics was given but the symptoms was not improved after discharged, orthopnea was noted at home, but no pitting edema. Body weight loss, poor appetite also noted for about few weeks.
    This time, while he was awake and went to bathroom in 2016/05/12 morning, weakness and consciousness loss was noted and he was sent to 亞東 hospital for evaluation, brain CT showed no ICH. Pulseless was detected and CPCR was initiated for 5 monutes and ROSC was achieved. He was transfer to NTUH ER for further treatment. At arrival, T/P/R: 36.8/124/24, BP: no dectected, E4M4Vt. Lab data showed leukocytosis compaired to 05/06 data, no liver or renal function impairment, no elevated cardiac enzyme, EKG showed sinus tachycardia. Whole body CT showed right side pleural effusion, enlarged liver metastic tumor, no evidence of bowel perferation. NG was inserted and bloody content was noted. Under the impression of septic shock with transient brain hypoperfusion, he was admitted for further treatment.


Family History:
Medication Allergy:No  病人自述 2014/04/13
No  病人自述 2014/04/10
No  病人自述 2014/04/11
No  舊病歷資料 2016/01/28
No  病人自述 2015/08/04
No  病人自述 2015/07/27
No  舊病歷資料 2015/07/29
No  病人自述 2015/12/12
No  病人自述 2014/07/09
No  病人自述 2015/10/14
No  病人自述 2015/05/25
No  舊病歷資料 2015/05/29
No  病人自述 2016/02/20
No  病人自述 2014/05/26
No  病人自述 2016/03/21
Medication ADR:unknown
Allergy to Medical Device and Materials:No  病人自述 2014/04/13
UnClear  病人自述 2014/04/10
No  病人自述 2014/04/11
No  舊病歷資料 2016/01/28
No  病人自述 2015/08/04
No  病人自述 2015/07/27
No  舊病歷資料 2015/07/29
No  病人自述 2015/12/12
No  病人自述 2014/07/09
No  病人自述 2015/10/14
No  病人自述 2015/05/25
No  舊病歷資料 2015/05/29
No  病人自述 2016/02/20
No  病人自述 2014/05/26
No  病人自述 2016/03/21
Current Medication:
NTUH:警 Levophed 4 mg/4 mL /amp 8 mg QD cIF 2 days
Beesix (VIT.B6) 50 mg/tab 1 tab QD PO 28 days
B.C. /cap 1 cap QD PO 28 days
自費 Proheparum /tab 1 tab QD PO 28 days
(管4) Ultracet tab /tab 1 tab TID PO 28 days
Prometin 5 mg/tab 1 tab BIDAC30 PO 28 days
摩 Mopride FC 5 mg/tab 1 tab BID PO 28 days
SOLAXIN 200 mg/tab 1 tab TIDPC PO 28 days
Other:
中草藥:nil
保健食品:nil
Past Medical History:
Hospitalization:入院日期:2014_05_26 出院日期:2014_05_29 診斷:Malignant neoplasm of descending colon
入院日期:2015_10_14 出院日期: 診斷:Malignant neoplasm of descending colon
入院日期:2015_06_10 出院日期: 診斷:Malignant neoplasm of descending colon
入院日期:2016_04_16 出院日期:2016_04_18 診斷:Colon cancer, descending colon
入院日期:2016_03_21 出院日期:2016_03_28 診斷:Gastritis
入院日期:2016_02_20 出院日期:2016_02_22 診斷:Colon cancer, descending colon
入院日期:2016_01_28 出院日期:2016_01_30 診斷:Colon cancer, descending colon
入院日期:2015_12_12 出院日期:2015_12_14 診斷:Malignant neoplasm of descending colon
入院日期:2015_11_15 出院日期:2015_11_17 診斷:Malignant neoplasm of descending colon
入院日期:2015_10_14 出院日期:2015_10_16 診斷:Malignant neoplasm of descending colon
入院日期:2015_09_10 出院日期:2015_09_16 診斷:Malignant neoplasm of descending colon
入院日期:2015_07_27 出院日期:2015_08_19 診斷:Malignant neoplasm of descending colon
入院日期:2015_05_25 出院日期:2015_05_31 診斷:Malignant neoplasm of descending colon
入院日期:2014_07_09 出院日期:2014_07_19 診斷:Malignant neoplasm of descending colon

Past Surgical History:2014_05_26  
2014_05_26  Left side Port-A implantation via percutaneous puncture
2014_07_11  Closure of loop ileostomy
2015_05_28  Radiofrequency ablation
2015_07_29  Right hemicolectomy + hepatic RFA + intra-abdominal seeding excision + intra-abdominal chemotherapy + ileostomyRadiofrequency ablation
Travel History:

Birth History(for pediatric patients):
Vaccination History:
Growth and Development History:
Maternal History(2y/o): 
社會心理相關評估(Psychosocial Assessment) 
Social Economic and Personal History
教育程度:國中
職業:退休
宗教信仰:無
婚姻狀態:已婚
使用語言:國語 台語 
口述血型:O，RH:不清楚，輸血反應:沒輸過血
抽煙:沒有，已戒煙:3年
喝酒:沒有
檳榔:沒有
物質濫用:不知道

Psychological History and Evaluation
意識狀態:警醒
認知功能:異常 時間障礙 地點障礙 記憶力障礙 計算能力障礙
精神情緒狀態:異常 焦慮 躁動 
安全問題:有 其他 管路安全、預防跌倒
睡眠形態:正常  

Nutritional Screen
攝食情形:
排便狀態:正常
BMI:17.7

Fall Risk Assessment
總分:9
(>=3分進行不倒翁計畫，請開預防跌倒醫囑) 
系統性回顧(Review of System) 
1. Systemic: no fever ,no BW loss ,no easy-fatigability ,no change of appetite ,no dizziness 
2. Skin: no petechiae ,no purpura ,no itching ,no local redness and swelling ,no papules 
3. HEENT: no hearing loss ,no nasal discharge ,no sore throat,no  headache
4. Cardiovascular:no palpitation ,no exertional of dyspnea 
5. Respiratory:no dyspnea ,no chest pain ,no cough ,no sputum production 
6. GI:no anorexia ,no nausea ,no vomiting ,no constipation ,no diarrhea ,no melena ,no change of bowel habit ,no small caliber of stool ,no tenesmus ,no flatulence ,no abdominal pain
7. Urogenital:no flank soreness ,no hematuria ,no urinary frequency ,no urgency ,no dysuria , no hesitancy ,no nocturia ,no polyuria ,no oliguria  
8. Musculoskeletal:no Back pain ,no bone pain ,no joint pain

系統性回顧(Review of System) (■:positive, □:negative)
1.Systemic: □fever, □chills, □easy-fatigability, □consciousness disturbance
            □weight change, □night sweats, □heat/cold intolerance, □thirsty
            □diffuse arthralgias/myalgias, □insomnia
2.Skin: □rash, □pruritis, □dryness, □ulcers, □color changes, □moles, □plaque
        □hair loss, □hirsutism, □telangiectasia □petechiae, □purpura
3.Head: □headache, □dizziness, □vertigo, □alopecia, □head trauma 
4.Eyes: □ocular pain, □diplopia, □vision loss, □blurred vision, □redness, 
        □photophobia, □excess tearing 
        □poor visual acuity, □cataracts, □glaucoma
5.Ears/Nose: □otalgia, □otorrhea, □hearing impairment, □tinnitus, 
             □sinus pain, □nasal congestion, □rhinorrhea, □epistaxis, □anosmia
6.Mouth/Throat: □oral ulcer, □gum bleeding, □dental problems
                □sore throat, □dysphagia, □odynophagia, □hoarseness
7.Cardio-Respiratory: □cough, □sputum, □dyspnea:at rest/exertional, 
                      □pleuritic pain, □tachypnea, □hemoptysis, □chest tightness,
                      □orthopnea, □paroxysmal nocturnal dyspnea, □syncope,
                      □palpitation, □intermittent claudication
8.Gastrointestinal: □anorexia, □nausea, □vomiting:bilious/feculent, □hematemesis  
                    □heartburn, □acid regurgitation, □belching, □hiccup
                    □abdominal pain:______, □hunger pain, 
                    □diarrhea, □constipation, □melena, □clay-colored stool
                    □change of bowel habit, □tenesmus, □flatulence
9.Genito-urinary: □urinary frequency, □urgency, □dysuria, □hesitancy,
                  □incontinence, □nocturia, □polyuria, □oliguria 
                  □small stream of urine, □cloudy urine, □hematuria,
                  □flank pain, □impotence, □abnormal sexual exposure
10.Musculoskeletal: □bone pain, □arthralgia, □myalgia, □back pain
                    □joint stiffness, □cramps, □fractures
11.Neurological: □numbness, □paresis/plegia, □convulsion, □paresthesia, □ataxia, 
                 □resting tremor, □gait disturbance,  
12.Psychiatric: □insomnia, □memory loss, □anxiety, □panic, □confusion
                □hallucination, □delusion, □suicidality 
身體檢查(Physical Examination) 
BH: 160 cm,  BW: 45.3 kg,
T: 37.6 °C,  P: 137 bpm,  R: 25 /min,
BP: 153 / 89 mmHg,
Pain score: 0 ,

Neurological Examination: 
. Consciousness: 
. Muscle power: 
. Gait:
HEENT: grossly normal, conjunctiva: pink, sclera: anicteric
             Pupil: isocoric,  3mm/ 3mm
Light reflex: L/R: +/+, EOM: full and free
Neck: supple, no JVE  no LAP  no Goiter no Carotid bruit
Chest: symmetric expansion, breath sound: clear
Heart: RHB, no murmur
Abdomen: soft and flat, bowel sound: normoactive
         Liver/ spleen: impalpable
         no Tenderness   no Rebound tenderness  
Back: No knocking tenderness
Extremities: Freely movable, no pitting edema ; no cyanosis  
Skin: no Skin rash  

[Neurological Examination]
Consciousness: alert, E4M6V5
Cranial nerve                                                   
I    Not checked
II   VA- not checked; VF(confrontation test): no defect
Pupil size: 2 mm/2 mm, LR: +/+
III, IV, VI
    EOM: Full and free; No ptosisV    Corneal reflex: R / L= +/ +
      Sensory: intact
      Motor : masseter muscle = no weakness
VII    No facial palsy
VIII   Hearing ability : grossly intact
IX, X  Gag reflex: R / L = +/+ ;soft palate elevation- symmetric  
XI    SCM / Trapezius muscle : no weakness
XII   Tongue protrusion: no deviation, no fasciculation; Tongue atrophy (-)

Motor
Muscle power: normal
Deep tendon reflex: normal
Muscle tone-no spasticity or flaccidity 
Fasciculation-nil 
Muscle atrophy (-); Muscle hypertrophy (-)

Sensation
Pinprick: intact
Temperature: intact
Vibration: intact
Proprioception: intact

Vestibular system and coordination
F-N-F –no dysmetria 
RAM- no dysdiadochokinesia
Romberg test (-)
Tandem gait: stable

Extrapyramidal system
Rigidity (-), Rest tremor (-), Bradykinesia(-)

Sphincter
Anal sphincter tone: intact
Urethra sphincter tone: intact 
檢驗紀錄(Laboratory Report) 
*********檢驗室:RL***********

群組:General BioChemistry

               TP            LDH          
time/item      (g/dL)        (U/L)        
1050512 [1103] 4.0           274          
群組:Blood pH/Gas

               PH            PCO2          PO2           HCO3          BaseExcess   
time/item      (*)           (mmHg)        (mmHg)        (mmol/L)      (mmol/L)     
1050512 [1103] 7.389         50.3          230.0         30.7          5.5          
*********檢驗室:RL***********

群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1050416 [0958] 8.31          4.35          13.2          39.9          91.7         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1050416 [0958] 30.3          33.1          269           16.3          -            
群組:WBC Classification

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1050416 [0958] 0.0           0.0           0.0           0.0           0.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1050416 [0958] 74.9          1.6           0.4           7.8           15.3         
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1050416 [0958] 0.0           0.0           0             -            


*********檢驗室:PO***********

群組:

               Sugar(One to 
               uch)         
time/item      (*)          
1050512 [0821] 128          
1050512 [1106] 113          
*********檢驗室:RL***********

群組:

               Troponin-T    CK-MB         Mucus(S)     
time/item      (ng/L)        (ng/mL)       (*)          
1050512 [0830] 27.36         5.49                       
1050512 [0914]                             -            
群組:SEDIMENT

               RBC(S)        WBC(S)        EpithCell(S)  Cast(S)       Crystal(S)                 
time/item      (/HPF)        (/HPF)        (/HPF)        (/LPF)        (*)          
1050512 [0914] >100          10-20         5-10          -             Ca-OX(+) Amm 
                                                                    .urate(+)    
               Bacteria      Others(S)    
time/item      (*)           (*)          
1050512 [0914] 2+            -            
群組:MULTISTIX

               Sp. Gr.(C)    pH(C)         Protein(C)    Glu.(C)       Ketones(C)   
time/item      (*)           (*)           (mg/dL)       (mg/dL)       (*)          
1050512 [0914] 1.020         6.0           100 ( 2+ )    -             1+           
               O.B.(C)       Urobil.(C)    Bil.(C)       Nitrite(C)    WBC(C)       
time/item      (*)           (mg/dL)       (*)           (*)           (*)          
1050512 [0914] 3+            ≦1.5          -             -             2+           
               Color         Turbidity    
time/item      (*)           (*)          
1050512 [0914] Yellow        +            
群組:Biochemistry

               BUN           CRE           Na            K             Ammonia N    
time/item      (mg/dL)       (mg/dL)       (mmol/L)      (mmol/L)      (μmol/L)     
1050512 [0830] 14.3          0.5           135           4.6           32           
               T-BIL         Lipase        Ca            Mg            LacticAcid   
time/item      (mg/dL)       (U/L)         (mmol/L)      (mmol/L)      (mmol/L)     
1050512 [0830] 0.71          200           2.20          0.88          1.39         
               CK           
time/item      (U/L)        
1050512 [0830] 56           
群組:Yes

               hsCRP         NT-pro BNP   
time/item      (mg/dL)       (pg/mL)      
1050512 [0830] 5.55          911.8        
群組:Coagulation

               PT            PTT           PT INR       
time/item      (sec)         (sec)         ()           
1050512 [0830] 12.0          30.8          1.11         
群組:General BioChemistry

               ALB           ALT          
time/item      (g/dL)        (U/L)        
1050512 [0830]               38           
1050512 [0847] 3.2                        
群組:WBC Classification

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1050512 [0830] 0.0           0.0           0.0           0.0           0.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1050512 [0830] 83.3          0.1           0.1           7.5           9.0          
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1050512 [0830] 0.0           0.0           0             -            
群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1050512 [0830] 12.06         3.92          11.7          36.5          93.1         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1050512 [0830] 29.8          32.1          257           15.7          -            
*********檢驗室:BK***********

群組:Yes

               antibody scr 
               een(New Lis)               
time/item      (*)          
1050512 [0830] Negative     
群組:Blood Type

               ABO Typing    RH Typing    
time/item      (*)           (*)          
1050512 [0830] O             Positive     
*********檢驗室:RL***********

群組:Biochemistry

               CRE           Na            K             CK           
time/item      (mg/dL)       (mmol/L)      (mmol/L)      (U/L)        
1050506 [0723] 0.6           137           4.0                        
1050506 [0744]                                           36           
群組:Blood pH/Gas

               PH            PCO2          PO2           HCO3          BaseExcess   
time/item      (*)           (mmHg)        (mmHg)        (mmol/L)      (mmol/L)     
1050506 [0723] 7.331         58.2          31.8          31.0          4.8          
群組:General BioChemistry

               ALT          
time/item      (U/L)        
1050506 [0723] 39           
群組:WBC Classification

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1050506 [0723] 0.0           0.0           0.0           0.0           0.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1050506 [0723] 57.7          1.6           0.3           12.5          27.9         
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1050506 [0723] 0.0           0.0           0             -            
群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1050506 [0723] 3.77          4.52          13.4          41.4          91.6         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1050506 [0723] 29.6          32.4          239           15.8          -            
群組:Coagulation

               PT            PTT           PT INR       
time/item      (sec)         (sec)         ()           
1050506 [0723] 10.9          32.4          1.03 
檢查紀錄(Examination Report) 
nil 
影像報告(Imaging Report) 
CT With/Without Contrast-Abdomen 醫令: CT With/Without Contrast-Abdomen 報告醫師: 葉建德 影像時間: 2016/05/12 09:26 (33072B3M) 發報告時間: 2016/05/12 10:30 Abdomen and pelvis CT with/without contrast enhancement shows
1. Post-op change of left hemicolectomy. s/p ileostomy. 
2. Multiple peritoneal seeding tumors, with invasion of liver parenchyma. Some hepatic lesions are enlarged as compared to previous CT on 2016/2/2.
3. No ascites. 
4. Left renal cysts. 
5. Unremarkable gallbladder, adrenal glands, pancreas, spleen.
6. No enlarged paraaortic or inguinal lymphadenopathy. 
7. Enlarged prostate. 
8. Thoracolumbar spondylosis with marginal spur formation at multiple levels. (previous) compression fracture(s) and wedge deformity or decrease in height at multiple lumbar spine. 
9. Placement of a nasogastric tube and a foley catheter.
CT With/Without Contrast-Chest 醫令: CT With/Without Contrast-Chest 報告醫師: 陳世杰 影像時間: 2016/05/12 09:26 (33072B2M) 發報告時間: 2016/05/12 12:16 CT of chest without & with iv contrast shows:
1. comparison: 20160202 CT. 
2. left Port-A insertion. small LN at mediastinum, stable. 
3. interlobular thickening at bilateral lungs. 
4. bilateral pleural seedings. right pleural effusion, increased.
5. several tiny ~ small bilateral lung metastasis nodules.

suggest follow & correlated with clinical manifestation.
Please refer to detailed corresponded report(s) and CT imaging of other body part(s).
CT With/Without Contrast-Pelvis 醫令: CT With/Without Contrast-Pelvis 報告醫師: 葉建德 影像時間: 2016/05/12 09:26 (33072B5M) 發報告時間: 2016/05/12 10:30 Abdomen and pelvis CT with/without contrast enhancement shows
1. Post-op change of left hemicolectomy. s/p ileostomy. 
2. Multiple peritoneal seeding tumors, with invasion of liver parenchyma. Some hepatic lesions are enlarged as compared to previous CT on 2016/2/2.
3. No ascites. 
4. Left renal cysts. 
5. Unremarkable gallbladder, adrenal glands, pancreas, spleen.
6. No enlarged paraaortic or inguinal lymphadenopathy. 
7. Enlarged prostate. 
8. Thoracolumbar spondylosis with marginal spur formation at multiple levels. (previous) compression fracture(s) and wedge deformity or decrease in height at multiple lumbar spine. 
9. Placement of a nasogastric tube and a foley catheter.
Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師: 簡寧 影像時間: 2016/05/12 08:48 (32001CYM) 發報告時間: 2016/05/12 12:16 normal heart size. bilateral pleural effusion. degenerative spondylosis at the thoracic spine. Placement of an endotracheal tube and a NG tube.
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 劉高郎 影像時間: 2016/05/06 07:36 (32001CXM) 發報告時間: 2016/05/06 13:02 EXAMINATION: Chest : PA View (Standing)
FINDINGS:
1. No evidence of subphrenic free air is noted. 
2. Left Port-A insertion from left subclavian vein is noted with tip in the superior vena cava. 
3. Small nodules in the left lower lung can not be excluded. 
4. Bilateral pleural effusions; 
5. Operative change in the left upper abdomen;.
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 葉建德 影像時間: 2016/04/18 08:31 (32001CXM) 發報告時間: 2016/04/19 18:45 normal heart size. atelectasis of bilateral lungs. bilateral pleural effusion. placement of a left Port-A catheter.
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 柯維鈞 影像時間: 2016/04/17 08:59 (32001CXM) 發報告時間: 2016/04/17 17:30 Chest PA shows placement of a left port A catheter. normal heart size. calcification of aorta. bilateral pleural effusion. hazy opacities at left lower lung field. degenerative change of the T spine. postoperative change of the left upper abdomen with placement of clips.
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 陳育青 影像時間: 2016/04/16 13:28 (32001CXM) 發報告時間: 2016/04/19 18:06 a port-A-cath. normal heart size. blunted bilateral costophrenic angles. bilateral patchy opacities.
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 簡寧 影像時間: 2016/04/16 21:02 (32001CXM) 發報告時間: 2016/04/18 22:24 normal heart size. increased infiltration in the bilateral lung fields. right pneumohydrothorax. suggest correlation with clinical manifestation. placement of a left port A catheter. post-operative changes with surgical clips at the LUQ of abdomen.
Whole body FDG (健保) 醫令: Whole body FDG (健保) 報告醫師: 路景竹 影像時間: 2016/04/13 11:21 (000TP006) 發報告時間: 2016/04/14 13:05 NUCLEAR MEDICINE STUDY: Whole body FDG PET(Positron Emission Tomography).
RADIOPHARMACEUTICAL: Intravenous  MBq 18FDG (2-[Flurorine-18] fluoro-2-deoxy-D-glucose).
CLINICAL HISTORY: Splenic flexure colon cancer with colonic obstruction, pT4aN1bM0, stage IIIB, status post loop T-colostomy on 2014/4/15, status post laparoscopic left hemicolectomy with protective ileostomy on 2014/4/22, status post port-A implantation on 2014/5/26, status post chemotherapy with FOLFOX on 2014/5-10. 
SCINTIGRAPHIC FINDINGS:
          Whole body PET from vertex of the skull to mid thighs was performed 45 minutes and delayed 2 hours after intravenous injection of 18FDG. The computer reconstructed coronal and sagittal images disclosed:\
compared with prior study on 2015/10/15:
* Multiple new diffuse hot areas along bilateral pleura, left lung (fig.1-3, SUVmax=5.1), right lobe of liver (fig.4-5, SUVmax=8.4) and peritoneum (fig.6-7, SUVmax=5.4).
* SUV: standard uptake value. 
病理報告(Pathology Report) 
S1530037
Intestine,large,cecum,right hemicolectomy,adenocarcinoma,metastatic (serosal seedings),   
Intestine,small,ileum,right hemicolectomy,adenocarcinoma,metastatic (serosal seedings),   
Appendix,appendectomy,adenocarcinoma,metastatic (serosal seedings),   
Lymph node,regional,dissection,adenocarcinoma, metastatic (4/13),   
Soft tissue,neum, labeled as tumor seeding,perito excision,adenocarcinoma, metastatic    
 S1415214
Intestine,large,colon,splenic flexure,laparoscopic left hemicolectomy,adenocarcinoma    
Intestine,large,colon,additional proximal margin,resection,no evidence of malignancy    
Intestine,large,colon,additional distal margin,resection,no evidence of malignancy    
Lymph node,regional,lymphadenectomy,adenocarcinoma,metastatic (3/29),   
Omentum,omentectomy,chronic inflammation    
 S1427165
Intestine,small,ileum,ileostomy closure,chronic inflammation 
臆斷(Tentative Diagnosis) 
1. Colon cancer, adenocarcinoma, splenic flexure, pT4aN1bM0, stage IIIB, status post loop T-colostomy (2014/4/15), status post laparoscopic left hemicolectomy and protective loop ileostomy (2014/4/22), status post FOLFOX (I, 2014/5/27), status post closure of loop ileostomy (2014/7/11), PD with liver mets, status post RFA (II), status post FOLFIRI (I, 2015/5/29), PD with peritoneal seeding and pleural mets, status post right hemicolectomy + intra-abdominal seeding excision + intraabdominal chemotherapy + ileostomy (2015/7/29), s/p FOLFOXFIRI + Avastin (IV, C1D1=2015/9/14 ~ C4D1=2015/12/12), status post FOLFIRI (II, C1D1=2016/1/28 ~ C2D1=2016/2/20), status post FOLFIRI + AVASTIN (I, 2016/04/16)
2. Septic shock, suspected intra-abdominal infection related
3. Malignant pleural effusion, favored pleural seeding related, with suspected restrictive lung
4. Gastrointestinal bleeding, suspected ulcer bleeding related, small amount 
醫療需求與治療計畫(Medical Needs and Care Plan) 
*
Treatment Goal:
1. Keep ventilator support, try PSV weaning gradually
2. NPO and D50W support, consider EGD for bleeder dectect, use IV nesium first
3. Tazocin for intra-abdominal infection
4. Monitor end organ perfusion and function 
出院規劃(Discharge Planning) 
管路留置狀況:有
靜脈管路留置(含Hickman / Port-A)：有 左鎖骨下 右手 
雙腔導管留置：無  
鼻胃管留置：有 16Fr. 
氣管管路留置：有 氣管內管  7.5mm 
胃造廔口：無  
尿管留置：有 Two way Foley 16Fr. 
膀胱造廔：無 
傷口引流管：無
其他導管：
日常生活功能分數：0
預期出院後居住場所：與家人同住 
預期出院後主要照顧者：自己 配偶 
出院規劃收案篩檢：高危病患 帶有管路 
主治醫師評論(VS Comments) 
I agree with the assessment of the intern. 
醫師姓名 
郭炳宏 主治醫師 
